Stromal Therapeutics Company
Stromal Therapeutics is the first biotechnological spin-off from the Kantonsspital St.Gallen. Stromal Therapeutics Building on the group’s unique domain expertise, the company has deployed state-of-the-art single-cell sequencing of human tissues to molecularly unravel the interplay of stromal tissue cytokines with the immune system
Employee Number:
1-10
Headquarters:
Basel, Basel-Stadt, Switzerland, Europe
Founded Date:
2018-11-01
Industry:
Lab Instruments, Reagents & Research Software
Super Industry:
Biopharma & Life Science Tools
Investors:
BaseLaunch
Ipo Status:
private
City:
Basel
Region:
Basel-Stadt
Country:
Switzerland
Founders:
Burkhard Ludewig